PHAXIAM Therapeutics S.A. (PHXM) — Strategic Asset Allocation Index
PHAXIAM Therapeutics S.A. (PHXM) has a Strategic Asset Allocation Index of 22.8% as of June 2024. Strategic assets (PP&E of €3.52 Million plus long-term investments of €-) total €3.52 Million, measured against net assets of €15.45 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
PHAXIAM Therapeutics S.A. Strategic Asset Allocation Index (2010–2023)
This chart shows how PHAXIAM Therapeutics S.A.'s Strategic Asset Allocation Index has evolved across 12 annual periods from 2010 to 2023. As of June 2024, the index stands at 22.8%, representing strategic assets of €3.52 Million against net assets of €15.45 Million EUR. Explore PHXM cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for PHAXIAM Therapeutics S.A. (2010–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for PHAXIAM Therapeutics S.A. from 2010 to 2023, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see PHAXIAM Therapeutics S.A. market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 15.2% | €3.90 Million | €3.90 Million | €- | €25.61 Million | ▲ +2.5 pp |
| 2022 | 12.7% | €2.98 Million | €2.98 Million | €- | €23.49 Million | ▼ -100.4 pp |
| 2021 | 113.1% | €25.83 Million | €25.83 Million | €- | €22.84 Million | ▲ +3.4 pp |
| 2020 | 109.7% | €29.11 Million | €29.09 Million | €17.00K | €26.54 Million | ▲ +68.0 pp |
| 2019 | 41.7% | €35.66 Million | €35.64 Million | €17.00K | €85.56 Million | ▲ +31.1 pp |
| 2018 | 10.6% | €15.37 Million | €15.27 Million | €91.00K | €145.60 Million | ▲ +8.6 pp |
| 2017 | 1.9% | €3.47 Million | €3.41 Million | €66.00K | €181.42 Million | ▼ -4.4 pp |
| 2016 | 6.3% | €2.25 Million | €2.25 Million | €- | €35.64 Million | ▲ +4.4 pp |
| 2015 | 1.9% | €918.00K | €918.00K | €- | €47.13 Million | ▼ -0.8 pp |
| 2014 | 2.7% | €967.00K | €967.00K | €- | €35.82 Million | ▼ -3.3 pp |
| 2013 | 6.0% | €813.00K | €813.00K | €- | €13.59 Million | ▼ -24.1 pp |
| 2010 | 30.1% | €1.20 Million | €1.20 Million | €- | €3.99 Million | — |